日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CSF d18:1 sphingolipid species in Parkinson disease and dementia with Lewy bodies with and without GBA1 variants

帕金森病和路易体痴呆(伴或不伴GBA1变异)患者的脑脊液d18:1鞘脂种类

Lerche, Stefanie; Wurster, Isabel; Valente, Enza Maria; Avenali, Micol; Samaniego, Daniela; Martínez-Vicente, Marta; Hernández-Vara, Jorge; Laguna, Ariadna; Sturchio, Andrea; Svenningsson, Per; France, Nicholas P; Barlow, Carrolee; Sankaranarayanan, Sethu; Brockmann, Kathrin

G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage

G2019S 选择性 LRRK2 激酶抑制剂可消除线粒体 DNA 损伤

Nicholas Pena, Tara Richbourg, Claudia P Gonzalez-Hunt, Rui Qi, Paul Wren, Carrolee Barlow, Natalie F Shanks, Holly J Carlisle, Laurie H Sanders

BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPTP301S mouse model of tauopathy

BCI-838 是一种口服 mGluR2/3 受体拮抗剂前药,可挽救 PS19 MAPTP301S 小鼠 tau 蛋白病模型中的学习行为缺陷

Georgina Perez-Garcia, Mesude Bicak, Jean-Vianney Haure-Mirande, Gissel M Perez, Alena Otero-Pagan, Miguel A Gama Sosa, Rita De Gasperi, Mary Sano, Carrolee Barlow, Fred H Gage, Benjamin Readhead, Michelle E Ehrlich, Sam Gandy, Gregory A Elder

Beneficial effects of physical exercise and an orally active mGluR2/3 antagonist pro-drug on neurogenesis and behavior in an Alzheimer's amyloidosis model

体育锻炼和口服 mGluR2/3 拮抗剂前药对阿尔茨海默病淀粉样变性模型中的神经发生和行为的有益影响

Georgina Perez Garcia #, Mesude Bicak #, Jacqueline Buros, Jean-Vianney Haure-Mirande, Gissel M Perez, Alena Otero-Pagan, Miguel A Gama Sosa, Rita De Gasperi, Mary Sano, Fred H Gage, Carrolee Barlow, Joel T Dudley, Benjamin S Glicksberg, Yanzhuang Wang, Benjamin Readhead, Michelle E Ehrlich, Gregory

Differential Inhibition of LRRK2 in Parkinson's Disease Patient Blood by a G2019S Selective LRRK2 Inhibitor

G2019S 选择性 LRRK2 抑制剂对帕金森病患者血液中的 LRRK2 进行差异抑制

Jessica M Bright, Holly J Carlisle, Alyssa M A Toda, Molly Murphy, Tyler P Molitor, Paul Wren, Kristin M Andruska, Enchi Liu, Carrolee Barlow

The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat

验证药物遗传学在识别适合接受米格司他治疗的法布里病患者中的应用。

Benjamin, Elfrida R; Della Valle, Maria Cecilia; Wu, Xiaoyang; Katz, Evan; Pruthi, Farhana; Bond, Sarah; Bronfin, Benjamin; Williams, Hadis; Yu, Julie; Bichet, Daniel G; Germain, Dominique P; Giugliani, Roberto; Hughes, Derralynn; Schiffmann, Raphael; Wilcox, William R; Desnick, Robert J; Kirk, John; Barth, Jay; Barlow, Carrolee; Valenzano, Kenneth J; Castelli, Jeff; Lockhart, David J

Utility of the wireless motility capsule and lactulose breath testing in the evaluation of patients with Parkinson's disease who present with functional gastrointestinal symptoms

无线动力胶囊和乳果糖呼气试验在评估伴有功能性胃肠道症状的帕金森病患者中的应用价值

Su, Andrew; Gandhy, Rita; Barlow, Carrolee; Triadafilopoulos, George

Utility of high-resolution anorectal manometry and wireless motility capsule in the evaluation of patients with Parkinson's disease and chronic constipation

高分辨率肛门直肠测压和无线动力胶囊在评估帕金森病合并慢性便秘患者中的应用价值

Su, Andrew; Gandhy, Rita; Barlow, Carrolee; Triadafilopoulos, George

Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused Agalsidase

当与输注阿加糖酶联合使用时,口服米格司他盐酸盐可提高法布里病患者体内活性α-半乳糖苷酶A的全身暴露量和组织水平。

Warnock, David G; Bichet, Daniel G; Holida, Myrl; Goker-Alpan, Ozlem; Nicholls, Kathy; Thomas, Mark; Eyskens, Francois; Shankar, Suma; Adera, Mathews; Sitaraman, Sheela; Khanna, Richie; Flanagan, John J; Wustman, Brandon A; Barth, Jay; Barlow, Carrolee; Valenzano, Kenneth J; Lockhart, David J; Boudes, Pol; Johnson, Franklin K

DNA variation and brain region-specific expression profiles exhibit different relationships between inbred mouse strains: implications for eQTL mapping studies

DNA变异和脑区特异性表达谱在近交系小鼠中表现出不同的关系:对eQTL定位研究的启示

Hovatta, Iiris; Zapala, Matthew A; Broide, Ron S; Schadt, Eric E; Libiger, Ondrej; Schork, Nicholas J; Lockhart, David J; Barlow, Carrolee